Essential Role for Cellular Phosphoglucomutase in Virulence of Type 3 Streptococcus pneumoniae
Open Access
- 1 April 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (4), 2309-2317
- https://doi.org/10.1128/iai.69.4.2309-2317.2001
Abstract
Synthesis of the Streptococcus pneumoniae type 3 capsule requires the pathway glucose-6-phosphate (Glc-6-P) → Glc-1-P → UDP-Glc → UDP-glucuronic acid (UDP-GlcUA) → (GlcUA-Glc)n. The UDP-Glc dehydrogenase and synthase necessary for the latter two steps, and essential for capsule production, are encoded by genes (cps3D andcps3S, respectively) located in the type 3 capsule locus. The phosphoglucomutase (PGM) and Glc-1-P uridylyltransferase activities necessary for the first two steps are derived largely through the actions of cellular enzymes. Homologues of these enzymes, encoded by cps3M and cps3Uin the type 3 locus, are not required for capsule production. Here, we show that cps3M and cps3U also are not required for mouse virulence. In contrast, nonencapsulated isolates containing defined mutations in cps3D andcps3S were avirulent, as were reduced-capsule isolates containing mutations in pgm. Insertion mutants that lacked PGM activity were avirulent in both immunologically normal (BALB/cByJ) and immunodeficient (CBA/N) mice. In contrast, a mutant (JY1060) with reduced PGM activity was avirulent in the former but had only modestly reduced virulence in the latter. The high virulence in CBA/N mice was not due to the lack of antibodies to phosphocholine but reflected a growth environment distinct from that found in BALB/cByJ mice. The reduced PGM activity of JY1060 resulted in enhanced binding of complement and antibodies to surface antigens. However, decomplementation of BALB/cByJ mice did not enhance the virulence of this mutant. Suppressor mutations, only some of which resulted in increased capsule production, increased the virulence of JY1060 in BALB/cByJ mice. The results suggest that PGM plays a critical role in pneumococcal virulence by affecting multiple cellular pathways.Keywords
This publication has 69 references indexed in Scilit:
- Biosynthesis of Type 3 Capsular Polysaccharide inStreptococcus pneumoniaeJournal of Biological Chemistry, 2000
- Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniaeMolecular Microbiology, 2000
- Capsule Genetics inStreptococcus pneumoniaeand a Possible Role for Transposition in the Generation of the Type 3 LocusMicrobial Drug Resistance, 1998
- MicroCorrespondenceMolecular Microbiology, 1997
- Type 3-specific synthase of Streptococcus pneumoniae (Cap3B) directs type 3 polysaccharide biosynthesis in Escherichia coli and in pneumococcal strains of different serotypes.The Journal of Experimental Medicine, 1996
- Genetic and molecular characterization of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3Molecular Microbiology, 1994
- Colocalization of X-Linked Agammaglobulinemia and X-Linked Immunodeficiency GenesScience, 1993
- SIMULTANEOUS PRODUCTION OF TWO CAPSULAR POLYSACCHARIDES BY PNEUMOCOCCUSThe Journal of Experimental Medicine, 1959
- CONTROL BY FACTORS DISTINCT FROM THE S TRANSFORMING PRINCIPLE OF THE AMOUNT OF CAPSULAR POLYSACCHARIDE PRODUCED BY TYPE III PNEUMOCOCCIThe Journal of Experimental Medicine, 1953
- THE PROTECTIVE ACTION OF A SPECIFIC ENZYME AGAINST TYPE III PNEUMOCOCCUS INFECTION IN MICEThe Journal of Experimental Medicine, 1931